Selected publications
-
Non-small cell lung cancer, version 5.2017: Clinical practice guidelines in oncology.
JNCCN Journal of the National Comprehensive Cancer Network.
2017
Article
GET IT
Times cited: 393 -
NCCN Guidelines®: Insights malignant pleural mesothelioma, version 3.2016.
JNCCN Journal of the National Comprehensive Cancer Network.
2016
Article
GET IT
Times cited: 29 -
NCCN guidelines® Insights: Non-small cell lung cancer, version 4.2016 Featured updates to the NCCN guidelines.
JNCCN Journal of the National Comprehensive Cancer Network.
2016
Article
GET IT
Times cited: 215 -
NCCN roundtable: What are the characteristics of an optimal clinical practice guideline?.
JNCCN Journal of the National Comprehensive Cancer Network.
2015
Academic Article
GET IT
Times cited: 7 -
Non-Small cell lung cancer, version 6.2015: Featured updates to the NCCN guidelines.
JNCCN Journal of the National Comprehensive Cancer Network.
2015
Review
GET IT
Times cited: 239 -
Lung cancer screening, version 1.2015: Featured updates to the NCCN guidelines.
JNCCN Journal of the National Comprehensive Cancer Network.
2015
Review
GET IT
Times cited: 68 -
Occult primary, version 3.2014; Featured updates to the NCCN guidelines.
JNCCN Journal of the National Comprehensive Cancer Network.
2014
Review
GET IT
Times cited: 15 -
Systemic therapy, clinical outcomes, and overall survival in locally advanced or metastatic pulmonary carcinoid: A brief report.
Journal of Thoracic Oncology.
2014
Academic Article
GET IT
Times cited: 15 -
Non-small cell lung cancer, version 1.2015: Clinical practice guidelines in oncology.
JNCCN Journal of the National Comprehensive Cancer Network.
2014
Academic Article
GET IT
Times cited: 108 -
Non-small cell lung cancer, version 2.2013: Featured updates to the NCCN guidelines.
JNCCN Journal of the National Comprehensive Cancer Network.
2013
Review
GET IT
Times cited: 267 -
Thymomas and thymic carcinomas.
JNCCN Journal of the National Comprehensive Cancer Network.
2013
Review
GET IT
Times cited: 22 -
Phase 2 study of pemetrexed and itraconazole as second-line therapy for metastatic nonsquamous non-small-cell lung cancer.
Journal of Thoracic Oncology.
2013
Academic Article
GET IT
Times cited: 78 -
American Cancer Society lung cancer screening guidelines.
Ca-A Cancer Journal for Clinicians.
2013
Review
GET IT
Times cited: 107 -
Non-small cell lung cancer: Clinical practice guidelines in oncology.
JNCCN Journal of the National Comprehensive Cancer Network.
2012
Review
GET IT
Times cited: 256 -
Antiemesis.
JNCCN Journal of the National Comprehensive Cancer Network.
2012
Review
GET IT
Times cited: 43 -
Lung cancer screening: Clinical practice guidelines in oncology.
JNCCN Journal of the National Comprehensive Cancer Network.
2012
Review
GET IT
Times cited: 164 -
Malignant pleural mesothelioma.
JNCCN Journal of the National Comprehensive Cancer Network.
2012
Review
GET IT
Times cited: 30 -
Occult primary.
JNCCN Journal of the National Comprehensive Cancer Network.
2011
Review
GET IT
Times cited: 14 -
Thymic malignancies.
JNCCN Journal of the National Comprehensive Cancer Network.
2010
Review
GET IT
Times cited: 11 -
Non-small cell lung cancer: Clinical practice guidelines in oncology.
JNCCN Journal of the National Comprehensive Cancer Network.
2010
Review
GET IT
Times cited: 438 -
Epidermal growth factor receptor, c-kit, and her2/neu immunostaining in advanced or recurrent thymic epithelial neoplasms staged according to the 2004 world health organization in patients treated with octreotide and prednisone: an eastern cooperative oncology group study.
Journal of Thoracic Oncology.
2010
Academic Article
GET IT
Times cited: 22 -
Antiemesis.
JNCCN Journal of the National Comprehensive Cancer Network.
2009
Conference Paper
GET IT
Times cited: 24 -
Dual inhibition of the epidermal growth factor receptor pathway with cetuximab and erlotinib: A phase I study in patients with advanced solid malignancies.
Oncologist.
2009
Academic Article
GET IT
Times cited: 20 -
Occult primary: Clinical practice guidelines in oncology.
JNCCN Journal of the National Comprehensive Cancer Network.
2008
Review
GET IT
Times cited: 2 -
Non-small cell lung cancer.
JNCCN Journal of the National Comprehensive Cancer Network.
2008
Review
GET IT
Times cited: 30 -
Small cell lung cancer.
JNCCN Journal of the National Comprehensive Cancer Network.
2008
Academic Article
GET IT
Times cited: 5 -
NCCN Task Force report: Positron Emission Tomography (PET)/Computed Tomography (CT) scanning in cancer.
JNCCN Journal of the National Comprehensive Cancer Network.
2007
Academic Article
GET IT
Times cited: 82 -
Antiemesis: Clinical practice guidelines in Oncology™.
JNCCN Journal of the National Comprehensive Cancer Network.
2007
Review
GET IT
Times cited: 42 -
Non-small cell lung cancer: Clinical Practice Guidelines in Oncology™.
JNCCN Journal of the National Comprehensive Cancer Network.
2006
Review
GET IT
Times cited: 126 -
Small cell lung cancer: Clinical Practice Guidelines in Oncology™.
JNCCN Journal of the National Comprehensive Cancer Network.
2006
Review
GET IT
Times cited: 37 -
Neuroendocrine tumors: Clinical Practice Guidelines in Oncology™.
JNCCN Journal of the National Comprehensive Cancer Network.
2006
Conference Paper
GET IT
Times cited: 9 -
Occult primary cancer: Clinical practice guidelines.
JNCCN Journal of the National Comprehensive Cancer Network.
2005
Review
GET IT
Times cited: 2 -
Surgical resection of limited disease small cell lung cancer in the new era of platinum chemotherapy: Its time has come.
Journal of Thoracic and Cardiovascular Surgery.
2005
Academic Article
GET IT
Times cited: 129 -
Antiemesis clinical practice guidelines in oncology.
JNCCN Journal of the National Comprehensive Cancer Network.
2004
Review
GET IT
Times cited: 7 -
Update: NCCN non-small cell lung cancer clinical practice guidelines.
JNCCN Journal of the National Comprehensive Cancer Network.
2004
Academic Article
GET IT
Times cited: 7 -
NCCN antiemesis practice guidelines.
ONCOLOGY.
1997
Academic Article
GET IT
Times cited: 49